After launching IPO, promising SA biotech still chasing profitability


The company's CEO believes a multinational presence could put it on the road to riches.

Previous Lenexa's Vytelle raises $20M Series B round
Next CADA looking at acquiring Urban Elements, Urban Capital downtown development sites